Schedule 13G ownership disclosure

Tokai Pharmaceuticals Inc

Security class unavailable · CUSIP: 88907J107

Event date: 2014-10-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-14-378426
Form type
SC 13G
Filer
Novo Holdings A/S
CIK
CIK 1388325
Filed
Oct 22, 2014
Reporting period
Oct 13, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub